CKDXF (Opthea) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Opthea ROE % Adjusted to Book Value?

Opthea's ROE % for the quarter that ended in Jun. 2024 was 0.00%. Opthea's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Opthea's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Opthea ROE % Adjusted to Book Value Historical Data

The historical data trend for Opthea's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea ROE % Adjusted to Book Value Chart

Opthea Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-3.01

-15.51

-10.96

Opthea Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-16.09	-28.45	-	-	-

Competitive Comparison of Opthea's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Opthea's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opthea's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Opthea's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Opthea's ROE % Adjusted to Book Value falls into.

Opthea ROE % Adjusted to Book Value Calculation

Opthea's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Opthea's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Opthea ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Opthea's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (OTCPK:CKDXF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

OPT:USA UKJ:Germany OPT:Australia

Address

650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141

Website

https://www.opthea.com

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.